Researchers advance therapeutic West Nile vaccine; autism linked to rainy days;

Vaccine Research

Researchers are developing a DNA-based vaccine against the dreaded West Nile virus, which can be transmitted from animals to humans. The unique feature of this vaccine is that it is also effective after onset of the disease, for it has therapeutic properties. Release

Researchers at the Moores Cancer Center at the University of California, San Diego are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia. Release

Integrated BioTherapeutics recently won a contract from the National Institute of Allergy and Infectious Diseases to do research on a new Ebola vaccine. Report

Cornell University researchers say that autism occurs more frequently among children living in rainy climates. Report

Vaccine market

A new predictive model shows that vaccinating infants with 7 valent pneumococcal conjugate vaccine--the current recommendation--not only saves lives and money during a normal flu season by preventing related bacterial infections; it also would prevent more than 357,000 deaths during an influenza pandemic, while saving $7 billion in costs. Release

Virogen has received purchase orders totaling $400,000 from its Asian and Middle Eastern distributors for its vaccine to combat Newcastle disease, a disease that kills chickens worldwide. Release

Suggested Articles

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…

NIH and Moderna will need a coronavirus vaccine manufacturer, and and no major pharmaceutical company has stepped up.

GlaxoSmithKline’s vaccines unit has been a bright spot for the company, but its performance doesn’t make it immune to staff cuts.